Author Topic: Great Resource for OTC Investors Updated  (Read 452 times)


  • Newbie
  • *
  • Posts: 42
    • OTC Newsletter
Great Resource for OTC Investors Updated
« on: February 26, 2020, 06:16:58 AM »
Dear fellow CoBFers who invest in OTC,

As you might remember from 2017 to 2019 I used to run a newsletter focused on the OTC market.

During that time, I scoured the notoriously inefficient market for companies that are meaningful and exhibit an investment opportunity. No frauds, no pump and dumps. Only companies that are of interest to the serious enterprising investor.

I like to think that I looked at every company in the OTC market at least twice. I went the A to Z route a couple of times, I maintained many simple screeners, I tracked Form 25s, 15s and much more. Given the sheer size of the market, one canít be completely sure of his/her coverage of the market, but I believe my reach is formidable.

In late 2018 I decided to compile all of the past research tied to the newsletter and offer it to investors. Just in case you missed it, I am now offering an updated and discounted version of my Svendaís Manual.

What I have added are the reports from 2019 which have coverage of over 100 stocks over 80 pages. Adding further reference points for your own OTC research.

I have also added a folder filled with financials tied to 36 dark stocks. Thus, you will be able to also expand your financials database.

You can find samples of the manual here -

As I like to say, simply knowing about an OTC company will make sure you are halfway in discovering an investment opportunity.

These documents will allow you to achieve that and greatly reduce the risk of you missing out on the next OTC opportunity. I believe it will be especially useful when the next crisis comes around.

You can buy the document through this PayPal link - 

Once you purchase, you will receive the full PDF documents straightaway.

Join the ranks for already content owners of the manual such as Andrew Kuhn of Focused Compounding -, David Flood of Elementary Value - and others.

I will greatly appreciate any feedback.



Financial Disclosure: I may own shares in the companies listed in the manual. Trading in OTC shares carries specific risks that one needs to understand before initiating a position. Due diligence is essential.
Focused on Building Walker's Manual 2.0 - Feel free to email me at

My favorite investment? Buying a house for the price of the bricks.